Bull
$4.61
Szenariopreis
$15.820
+7.880 (+49.81%)Zum Schluss
Hyperion DeFi, Inc. is engaged in building a long-term strategic treasury of Hyperliquid’s native token, HYPE. The Company is focused on providing simplified access to the Hyperliquid ecosystem. It is also developing its proprietary Optejet User Filled Device (UFD) that is designed to work with a variety of topical ophthalmic liquids, including artificial tears and lens rewetting products. The Optejet is useful in chronic front-of-the-eye diseases due to its ease of use, enhanced safety and tolerability, and potential for superior compliance versus standard eye drops. Together, these benefits may result in higher treatment compliance and better outcomes for patients and providers. It has launched its cryptocurrency treasury reserve, which is native to the decentralized digital asset exchange and Layer-1 blockchain, Hyperliquid. Hyperliquid is a layer one blockchain (L1) written and optimized from first principles.
HC Wainwright & Co.
$2
2025-03-21
HC Wainwright & Co.
2025-03-21
Kursziel
$2
HC Wainwright & Co.
$2
2025-02-06
HC Wainwright & Co.
2025-02-06
Kursziel
$2
Ladenburg Thalmann
—
2024-11-18
Ladenburg Thalmann
2024-11-18
Kursziel
—
HC Wainwright & Co.
$2
2024-11-18
HC Wainwright & Co.
2024-11-18
Kursziel
$2
Brookline Capital
—
2024-11-15
Brookline Capital
2024-11-15
Kursziel
—
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

EXCLUSIVE: June's 20 Most-Searched Tickers On Benzinga Pro — Where Do CoreWeave, Nvidia, Apple Stock Rank?

Eyenovia Adds $10 Million in HYPE to its Treasury Holdings in Preparation for Strategic Onchain Engagement

Eyenovia Announces Co-Branded Validator with Kinetiq

Eyenovia, Inc. Acquires $50 Million in HYPE Tokens, Plans Validator Deployment and FDA Registration for Optejet UFD

Crude Oil Moves Higher; US Weekly Jobless Claims Decline
Hyperion DeFi, Inc. is engaged in building a long-term strategic treasury of Hyperliquid’s native token, HYPE. The Company is focused on providing simplified access to the Hyperliquid ecosystem. It is also developing its proprietary Optejet User Filled Device (UFD) that is designed to work with a variety of topical ophthalmic liquids, including artificial tears and lens rewetting products. The Optejet is useful in chronic front-of-the-eye diseases due to its ease of use, enhanced safety and tolerability, and potential for superior compliance versus standard eye drops. Together, these benefits may result in higher treatment compliance and better outcomes for patients and providers. It has launched its cryptocurrency treasury reserve, which is native to the decentralized digital asset exchange and Layer-1 blockchain, Hyperliquid. Hyperliquid is a layer one blockchain (L1) written and optimized from first principles. It operates in the Healthcare sector (PHARMACEUTICAL PREPARATIONS industry).
2 analysts cover EYEN: 2 rate it Buy, 0 Hold and 0 Sell.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.